tci Part B Insider - 2004 Issue 4

Coverage: CMS Announces TEB Decision

In Transmittal 6, issued Jan. 23, the Centers for Medicare & Medicaid Services announced it's adding coverage of thoracic electrical bioimpedance devices, which are used for a type of plethysmography. Since 1999, CMS has covered TEB only for the "noninvasive diagnosis or monitoring of hemodynamics in patients with suspected or known cardiovascular disease."  In its new policy, CMS gives more explicit guidance as to which conditions require TEB. They include differentiating cardiogenic from pulmonary causes of acute dyspnea, optimizing atrioventicular interval for patients with A/V sequential cardiac pacemakers, monitoring of continuous inotropic therapy for patients with terminal...

To read the full article, sign in and subscribe to tci Part B Insider.

Thank you for choosing Find-A-Code, please Sign In to remove ads.